Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sunscreen Group Remains Cloudy About FDA's Ingredient Evaluations

Executive Summary

PASS Coalition fails to find common ground with US FDA as the sunscreen access advocacy group urges significant changes to a draft guidance on safety testing for sunscreen ingredients.


Related Content

OTC Monograph Reform, User Fee Legislation Coming 'Any Day' – CHPA
Sunscreen Industry Asks FDA For Flexibility Despite Guidances' Rigidity
FDA Sunscreen Guidance: Absorption Data Is A MUsT For GRASE Review
Manufacturers Argue FDA Sunscreen Reviews Keep Outside Science In Shade
Sunscreen Guidances Underscore FDA Standards Aren’t Changing
Sunscreen Trade Groups Urge 'Modern' Risk Assessments For Ingredients
BASF Asks FDA To Weigh Whole Sunscreen TEAs, Not Separate Parts
FDA Denies Remaining Sunscreen TEAs, Offers Primer On GRASE, Resources





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts